TrademarkDir
PRODUCT INNOVATION. PATIENT IMPACT.
DEAD

Serial Number

88132411

Owner

Concert Pharmaceuticals, Inc.

Attorney

Patrick J. Concannon

Filing Date

Sep 26, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PRODUCT INNOVATION. PATIENT IMPACT. Trademark

Serial Number: 88132411

PRODUCT INNOVATION. PATIENT IMPACT. is a trademark filed by Concert Pharmaceuticals, Inc. on September 26, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Concert Pharmaceuticals, Inc. (21 trademarks)

65 Hayden Avenue, Suite 3000N
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

September 26, 2018

Registration Date

Not Registered

Published for Opposition

August 20, 2019

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 21, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 21, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 21, 2022 EXRA
SOU EXTENSION 5 GRANTED
Apr 20, 2022 EX5G
SOU EXTENSION 5 FILED
Apr 14, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 14, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2021 EXRA
SOU EXTENSION 4 GRANTED
Oct 12, 2021 EX4G
SOU EXTENSION 4 FILED
Oct 12, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 12, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2021 EXRA
SOU EXTENSION 3 GRANTED
Apr 15, 2021 EX3G
SOU EXTENSION 3 FILED
Apr 15, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 15, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2021 EXRA
SOU EXTENSION 2 GRANTED
Feb 16, 2021 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 10, 2021 AITU
NOTICE OF REVIVAL - E-MAILED
Nov 17, 2020 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Nov 16, 2020 TPEX
PETITION TO REVIVE-GRANTED
Nov 16, 2020 PETG
TEAS PETITION TO REVIVE RECEIVED
Nov 16, 2020 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 16, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 16, 2020 ABN6
SOU EXTENSION 2 FILED
Oct 15, 2020 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2020 EXRA
SOU EXTENSION 1 GRANTED
Apr 10, 2020 EX1G
SOU EXTENSION 1 FILED
Apr 10, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 10, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 15, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2019 CRFA
ASSIGNED TO LIE
Jul 12, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2018 NWOS
NEW APPLICATION ENTERED
Sep 29, 2018 NWAP

Related Trademarks

More from this Owner

CONCERT PHARMACEUTICALS INC. logo

CONCERT PHARMACEUTICALS INC.

PRODUCT INNOVATION. PATIENT IMPACT.

PRODUCT INNOVATION. PATIENT IMPACT.

CONCERT PHARMACEUTICALS INC.

CONCERT PHARMACEUTICALS INC.

LEQSELVI

LEQSELVI

LEQSELVI

LEQSELVI

RENZYNCE

RENZYNCE